J. Dimitroulakos

J. Squire, H. Yeger, J. Dimitroulakos, 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

Dual inhibition of Wnt and Yes‐associated protein signaling retards the growth of triple‐negative breast cancer in both mesenchymal and epithelial states

Lisheng Wang, Ha-Eon Song, Z. Yao, 2018, Molecular oncology.

miR-105 Inhibits Prostate Tumour Growth by Suppressing CDK6 Levels

M. A. Cabrita, C. Addison, Huijun Zhao, 2013, PloS one.

Activating Transcription Factor 3 as a Novel Regulator of Chemotherapy Response in Breast Cancer12

B. Vanderhyden, C. Nessim, J. Dimitroulakos, 2018, Translational oncology.

C-reactive Protein in HPV-Positive and HPV-Negative Oropharyngeal Cancer

Jennifer R. Rider, S. Johnson-Obaseki, Geoffrey Liu, 2018, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

327 Activating transcription factor 3 as a novel regulator and predictor of cisplatin response in human cancers

J. Dimitroulakos, A. O'Brien, 2010 .

miR Profiling Identifies Cyclin-Dependent Kinase 6 Downregulation as a Potential Mechanism of Acquired Cisplatin Resistance in Non-Small-Cell Lung Carcinoma.

T. Perkins, J. Bar, G. Goss, 2015, Clinical lung cancer.

Enhancement of cisplatin cytotoxicity by disulfiram involves activating transcription factor 3.

S. Reid, J. Dimitroulakos, A. O'Brien, 2012, Anticancer research.

miR Pro fi ling Identi fi es Cyclin-Dependent Kinase 6 Downregulation as a Potential Mechanism of Acquired Cisplatin Resistance in Non e Small-Cell Lung Carcinoma

T. Perkins, J. Bar, G. Goss, 2022 .

Focal Adhesion Kinase Inhibitors in Combination with Erlotinib Demonstrate Enhanced Anti-Tumor Activity in Non-Small Cell Lung Cancer

H. Sekhon, C. Addison, Huijun Zhao, 2016, PloS one.

HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis

M. Minden, L. Penn, W. Wong, 2002, Leukemia.

Sensitivity of cervical carcinoma cells to vesicular stomatitis virus‐induced oncolysis: Potential role of human papilloma virus infection

J. Bell, F. Le Boeuf, J. Weberpals, 2012, International journal of cancer.

Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cells

M. Minden, W. Wong, J. Dimitroulakos, 2001, Leukemia.

Increased sensitivity of acute myeloid leukemias to lovastatin-induced apoptosis: A potential therapeutic approach.

M. Minden, D. Hedley, L. Penn, 1999, Blood.

MYCN protein expression as a predictor of neuroblastoma prognosis.

B. Gallie, V. Ling, H. Yeger, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Targeting Hypoxia Sensitizes TNBC to Cisplatin and Promotes Inhibition of Both Bulk and Cancer Stem Cells

Lisheng Wang, C. Addison, Xuguang Li, 2020, International journal of molecular sciences.

Lovastatin Inhibits VEGFR and AKT Activation: Synergistic Cytotoxicity in Combination with VEGFR Inhibitors

D. Trinh, T. Zhao, C. Addison, 2010, PloS one.

Co-inhibition of mTORC1, HDAC and ESR1α retards the growth of triple-negative breast cancer and suppresses cancer stem cells

Lisheng Wang, Ha-Eon Song, Z. Yao, 2018, Cell Death & Disease.

Both bulk and cancer stem cell subpopulations in triple‐negative breast cancer are susceptible to Wnt, HDAC, and ERα coinhibition

Lisheng Wang, C. Addison, A. Arnaout, 2016, FEBS letters.

Does metformin usage improve survival in head and neck squamous cell carcinoma? A population-based study

S. Johnson-Obaseki, S. Hall, J. Dimitroulakos, 2018, Journal of Otolaryngology - Head & Neck Surgery.

A phase I study of high-dose rosuvastatin with standard dose erlotinib in patients with advanced solid malignancies

A. Oza, D. Jonker, G. Goss, 2016, Journal of Translational Medicine.

Assessment of Circulating LncRNAs Under Physiologic and Pathologic Conditions in Humans Reveals Potential Limitations as Biomarkers

D. Stewart, L. Pilote, L. McIntyre, 2016, Scientific Reports.

Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apoptosis: therapeutic implications.

L. Penn, M. Moore, S. Kamel‐Reid, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

HMG–CoA reductase mediates the biological effects of retinoic acid on human neuroblastoma cells: Lovastatin specifically targets P–glycoprotein–expressing cells

H. Yeger, J. Dimitroulakos, 1996, Nature Medicine.

Apoptosis: A Potential Therapeutic Approach Increased Sensitivity of Acute Myeloid Leukemias to Lovastatin-Induced

M. Minden, D. Hedley, L. Penn, 2013 .

Epidermal growth factor receptor-targeted therapy potentiates lovastatin-induced apoptosis in head and neck squamous cell carcinoma cells

G. Goss, I. Lorimer, J. Dimitroulakos, 2003, Journal of Cancer Research and Clinical Oncology.

Stage-dependent differential expression of microRNAs in colorectal cancer: potential role as markers of metastatic disease

C. Addison, D. Jonker, J. Bar, 2012, Clinical & Experimental Metastasis.

Stage-dependent differential expression of microRNAs in colorectal cancer: potential role as markers of metastatic disease

C. Addison, D. Jonker, J. Bar, 2011, Clinical & Experimental Metastasis.

Effect of statin use on oncologic outcomes in head and neck squamous cell carcinoma

S. Johnson-Obaseki, S. Hall, J. Dimitroulakos, 2018, Head & neck.

Lovastatin inhibits EGFR dimerization and AKT activation in squamous cell carcinoma cells: potential regulation by targeting rho proteins

K. Ding, T. Zhao, G. Goss, 2010, Oncogene.

Customized Viral Immunotherapy for HPV-Associated Cancer

J. Diallo, S. Johnson-Obaseki, Fuan Wang, 2017, Cancer Immunology Research.

The DNA repair proteins BRCA1 and ERCC1 as predictive markers in sporadic ovarian cancer

S. Doucette, G. Goss, J. Weberpals, 2009, International journal of cancer.

Cerivastatin triggers tumor-specific apoptosis with higher efficacy than lovastatin.

M. Minden, W. Wong, J. Dimitroulakos, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Rationally Designed 3D Hydrogels Model Invasive Lung Diseases Enabling High‐Content Drug Screening

W. Stanford, M. Shoichet, R. Tam, 2018, Advanced materials.

Correction to: HPV DNA in saliva from patients with SCC of the head and neck is specific for p16-positive oropharyngeal tumours

S. Johnson-Obaseki, L. Caulley, J. Dimitroulakos, 2018, Journal of Otolaryngology - Head & Neck Surgery.

Vulvar Squamous Cell Carcinoma (VSCC) as Two Diseases: HPV Status Identifies Distinct Mutational Profiles Including Oncogenic Fibroblast Growth Factor Receptor 3

H. Sekhon, G. Goss, J. Weberpals, 2017, Clinical Cancer Research.

Lovastatin Induces a Pronounced Differentiation Response in Acute Myeloid Leukemias

M. Minden, D. Hedley, L. Penn, 2000, Leukemia & lymphoma.

Lovastatin Induces Multiple Stress Pathways Including LKB1/AMPK Activation That Regulate Its Cytotoxic Effects in Squamous Cell Carcinoma Cells

J. Dimitroulakos, N. Niknejad, Khalil Dayekh, 2012, PloS one.

Monensin Inhibits Epidermal Growth Factor Receptor Trafficking and Activation: Synergistic Cytotoxicity in Combination with EGFR Inhibitors

S. Johnson-Obaseki, H. Sekhon, J. Weberpals, 2014, Molecular Cancer Therapeutics.

Small Molecule Therapeutics Monensin Inhibits Epidermal Growth Factor Receptor Traf fi cking and Activation : Synergistic Cytotoxicity in Combination with EGFR Inhibitors

S. Johnson-Obaseki, H. Sekhon, J. Weberpals, 2014 .

Selection of probes for fluorescence in situ hybridization analysis by differential display polymerase chain reaction of mRNA from rhabdomyosarcoma.

N. Plavsic, J. Squire, H. Yeger, 1996, Cancer genetics and cytogenetics.